Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Nodular regenerative hyperplasia causing portal hypertension in a patient with chronic graft versus host disease: response to sirolimus.

Choe H, Aldoss I, Chaudhary P, Donovan J, Petrovic L, Pullarkat V.

Acta Haematol. 2014;132(1):49-52. doi: 10.1159/000356736. Epub 2014 Jan 15. Review. No abstract available.

PMID:
24434665
2.

Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update.

Cutler C, Antin JH.

Curr Opin Hematol. 2010 Nov;17(6):500-4. doi: 10.1097/MOH.0b013e32833e5b2e. Review.

PMID:
20717025
3.

[Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].

Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D.

Gastroenterol Clin Biol. 1991;15(12):968-73. Review. French.

PMID:
1783253
4.

Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.

Rosenbeck LL, Kiel PJ, Kalsekar I, Vargo C, Baute J, Sullivan CK, Wood L, Abdelqader S, Schwartz J, Srivastava S, Abonour R, Robertson MJ, Nelson RP Jr, Cornetta K, Fausel CA, Farag SS.

Biol Blood Marrow Transplant. 2011 Jun;17(6):916-22. doi: 10.1016/j.bbmt.2010.09.017. Epub 2010 Dec 4.

5.
6.

Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.

Pidala J, Tomblyn M, Nishihori T, Field T, Ayala E, Perkins J, Fernandez H, Locke F, Perez L, Ochoa JL, Alsina M, Anasetti C.

Haematologica. 2011 Sep;96(9):1351-6. doi: 10.3324/haematol.2011.041236. Epub 2011 May 12.

7.

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.

Couriel DR, Saliba R, Escalón MP, Hsu Y, Ghosh S, Ippoliti C, Hicks K, Donato M, Giralt S, Khouri IF, Hosing C, de Lima MJ, Andersson B, Neumann J, Champlin R.

Br J Haematol. 2005 Aug;130(3):409-17.

PMID:
16042691
8.

[Sinusoidal portal hypertension secondary to nodular regenerative hyperplasia of the liver].

Gento Peña E, Martín Lorente JL, Echevarría Iturbe C, Pérez Alvarez JC, Sáez-Royuela F, López Morante A, Ojeda Giménez C.

Gastroenterol Hepatol. 1999 Apr;22(4):183-5. Review. Spanish.

PMID:
10349789
9.

Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphoma.

Mehta J.

J Clin Oncol. 2009 Oct 1;27(28):e138; author reply e139-40. doi: 10.1200/JCO.2009.23.9483. Epub 2009 Aug 31. No abstract available.

PMID:
19720890
10.

Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.

Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana F, Taïeb A.

Br J Dermatol. 2007 Mar;156(3):588-90. No abstract available.

PMID:
17300261
11.

Nodular regenerative hyperplasia of the liver graft after liver transplantation.

Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R.

Hepatology. 1994 Jul;20(1 Pt 1):88-94.

PMID:
8020909
12.

Nodular regenerative hyperplasia of the liver: an unusual cause of portal hypertension in childhood.

Alperstein G, Kahn E, Aiges H, Daum F.

Am J Dis Child. 1981 Jun;135(6):572-4. No abstract available.

PMID:
7234797
13.

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

Jurado M, Vallejo C, Pérez-Simón JA, Brunet S, Ferra C, Balsalobre P, Pérez-Oteyza J, Espigado I, Romero A, Caballero D, Sierra J, Ribera JM, Díez JL.

Biol Blood Marrow Transplant. 2007 Jun;13(6):701-6.

14.

Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.

Fraile P, Vazquez L, Caballero D, Garcia-Cosmes P, López L, San Miguel J, Tabernero JM.

Eur J Haematol. 2013 Aug;91(2):129-34. doi: 10.1111/ejh.12149. Epub 2013 Jun 28. Erratum in: Eur J Haematol. 2013 Oct;91(4):380. Pilar, Fraile [corrected to Fraile, Pilar]; Lourdes, Vazquez [corrected to Vazquez, Lourdes]; Dolores, Caballero [corrected to Caballero, Dolores]; Pedro, Garcia-Cosmes [corrected to Garcia-Cosmes, Pedro]; Lucia, López [corrected to López, Lucia]; Jesus, San Miguel [corrected to San Miguel, Jesus]; Jose Matias, Tabernero [corrected to Tabernero, Jose Matias].

PMID:
23710658
15.

Milkers' nodules complicated by erythema multiforme and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Slattery WR, Juckett M, Agger WA, Radi CA, Mitchell T, Striker R.

Clin Infect Dis. 2005 Apr 1;40(7):e63-6. Epub 2005 Mar 4.

PMID:
15824977
16.

Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Zupan IP, Zver S, Pretnar J.

Transplant Proc. 2002 Nov;34(7):2931-3. No abstract available.

PMID:
12431662
17.

Nodular regenerative hyperplasia of the liver with and without portal hypertension: a comparison.

Harada A, Nakanuma Y, Govindarajan S, Peters RL.

Ann Clin Lab Sci. 1986 Mar-Apr;16(2):155-62.

PMID:
3963734
18.

Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.

Yoshimi A, Yamamoto G, Goto T, Koike K, Kurokawa M.

Ann Hematol. 2012 Sep;91(9):1501-2. Review. No abstract available.

PMID:
22314841
19.

Graft-versus-host disease therapy: something else beyond glucocorticoids?

Martínez C, Urbano-Ispízua A.

Haematologica. 2011 Sep;96(9):1249-51. doi: 10.3324/haematol.2011.050534. No abstract available.

20.

Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.

Biecker E, Trebicka J, Fischer HP, Sauerbruch T, Lammert F.

Z Gastroenterol. 2006 May;44(5):395-8.

PMID:
16688657

Supplemental Content

Support Center